The Ultimate Guide to a Life Sciences IPO

The life sciences industry is in the middle of an IPO boom, with the 10 highest-valued biotech IPOs raising $3.

More

Meet Kelly Provost: A Leader in CFGI’s Life Sciences Capital Markets

Kelly Provost is a leader in CFGI’s Life Sciences Capital Markets practice and has dedicated her career to supporting companies that are trying to cure diseases and save lives, making a difference in the lives of people across the world.

More

Meet Melanie Kavanagh: A Committed Accounting and Finance Leader at CFGI’s SF Office

Melanie Kavanagh’s promotion to Partner has been an achievement in the making since the day she walked in the doors at CFGI in 2012.

More

Clene Nanomedicine Inc. Closes Business Combination with SPAC Tottenham Acquisition I Limited

CFGI’s Capital Markets team assisted Clene Nanomedicine (“Clene”) (NYSE: CLNN) with its SPAC merger with Tottenham Acquisition I Limited (“Tottenham”).

More